Skip to main content

and
  1. Article

    Open Access

    Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

    Epilepsy, a common multifactorial neurological disease, affects about 69 million people worldwide constituting nearly 1% of the world population. Despite decades of extensive research on understanding its unde...

    Chitra Rawat, Samiksha Kukal, Ujjwal Ranjan Dahiya in Journal of Neuroinflammation (2019)

  2. Article

    Open Access

    A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease

    PD is a progressive neurodegenerative disorder commonly treated by levodopa. The findings from genetic studies on adverse effects (ADRs) and levodopa efficacy are mostly inconclusive. Here, we aim to identify ...

    Debleena Guin, Manish Kumar Mishra, Puneet Talwar, Chitra Rawat in BMC Medical Genomics (2017)

  3. No Access

    Article

    Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach

    Over expression of ATP-binding cassette transporters is considered one of the major reasons for non-responsiveness to antiepileptic drugs. Carbamazepine (CBZ), one of first line antiepileptic drug is known to ...

    Gurpreet K Grewal, Khuraijam D Singh, Neha Kanojia, Chitra Rawat in Pharmaceutical Research (2017)

  4. No Access

    Article

    Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by loss of memory and other cognitive functions. AD can be classified into familial AD (FAD) and sporadic AD (SAD) based on he...

    Puneet Talwar, Juhi Sinha, Sandeep Grover, Chitra Rawat in Molecular Neurobiology (2016)